Previous close | 5.30 |
Open | 5.30 |
Bid | 7.30 |
Ask | 9.80 |
Strike | 50.00 |
Expiry date | 2024-11-15 |
Day's range | 5.30 - 5.30 |
Contract range | N/A |
Volume | |
Open interest | 31 |
Latest QCI Interpret release enhances performance of high-throughput NGS labs, improving turn-around time, diagnostic yield and quality of results // New features include bulk variant assessment, flagging of co-occurring variants and improved muti-user functionality for faster and more efficient workflows // Genomics are moving towards analyzing large, comprehensive gene panels, creating a need for enhanced scalabilityVenlo, the Netherlands, and Redwood City, California, June 13, 2024 (GLOBE NEW
ESG commitments recognized as strategic business investments bringing value to stakeholders, including customers and employees // Environment: 15% reduction in Scope 1 and 2 emissions in 2023 through green energy procurement, complemented by 7% decrease in plastic usage // Social: // Leveraging partnerships, QIAGEN broadens diagnostic access worldwide // Commits to goal of at least 40% women in leadership by 2027 // Governance: New Supplier Code of Conduct and Human Rights Committee, upholding h
35 new wet-lab tested digital PCR Microbial DNA Detection Assays on research platform GeneGlobe target a wide range of pathogens causing tropical diseases, sexually transmitted and urine tract infections // QIAcuity digital PCR technology enables precise and sensitive detection of pathogens, supporting infectious disease research and public health efforts // New assays add to QIAGEN’s comprehensive portfolio for microbial research showcased at ASM Microbe conference from June 13-17Venlo, the Net